148 results on '"Oxyphenbutazone adverse effects"'
Search Results
102. [Clinical experiences with realin (oxyphenbutazone and prednisolone) in progressive chronic polyarthritis].
103. Aplastic anaemia. I. Incidence and aetiology.
104. Ulcer of the cecum during oxyphenbutazone (tandearil) therapy.
105. [Study of renal function in patients with chronic inflammatory rheumatism under treatment with Tandearil].
106. Oxyphenbutazone-induced parotitis.
107. Pain in haemophilia.
108. Thrombocytopenia and L.E. cells after oxyphenbutazone.
109. [Stevens-Johnson syndrome after treatment with Tanderil].
110. Oxyphenbutazone (Tanderil) and blood dyscrasia.
111. [The connection between Tandearil and leukemia].
112. Aplastic anaemia. II. Drug-induced aplastic anaemia.
113. [Therapy of external eye diseases using Tanderil eye ointment].
114. [Allergy and surgery].
115. [Congenital factor 13 deficiency: severe abdominal hemorrhage after combined antiinflammatory therapy].
116. Therapeutic hazards of phenylbutazone and oxyphenbutazone in polymyalgia rheumatica.
117. Potentiation of anticoagulant therapy by oxyphenylbutazone. (A probable case).
118. Hemorrhage while on anticoagulant therapy precipitated by drug interaction.
119. [Use of antiphlogistics for athletic injuries].
120. [The Tanderil + prednisolone combination in osteoarthritis: its efficacy and tolerance].
121. Oxyphenbutazone and aplastic anemia.
122. Adverse reactions with long-term use of phenylbutazone and oxyphenbutazone.
123. [Gracidin intoxication--pondex psychosis. (Data on the psychopathological symptoms caused by anorexigenics)].
124. Immunological evidence of two forms of allergy to pyrazolone drugs.
125. Drug reactions. XII. Cutaneous reactions to anti-rheumatic drugs.
126. [Studies on the tolerance of Realin in rheumatic diseases].
127. [Long-term therapy of the chronic bronchitis syndrome using Tanderil].
128. [Effect of prednisolone and oxyphenbutazone on the ultrastructure of the human gastric mucosa].
129. [Phenylbutazone derivatives and pathology of the salivary glands].
130. [On a case of partial aplastic myelosis during rheumatic disease].
131. Oxyphenbutazone (tanderil) eye ointment.
132. Phenylbutazone and oxyphenbutazone.
133. Current causes of fixed drug eruptions.
134. [Oxyphenbutazone and leukemia--statistical aspects].
135. [The prevention of postoperative inflammation in ocular surgey by the use of Tanderil].
136. [Can Tanderil therapy induce struma?].
137. [Postoperative use of indomethacin in orthopedics].
138. [Clinical evaluation of the drug in chronic articular rheumatism--multi-organization cooperative studies of oxyphenbutazone based on the 7-day variability study].
139. [Crime committed during pondex psychosis].
140. [Controlled clinical trial of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370) and oxyphenbutazone in thrombophlebitis].
141. Fixed drug eruption to oxyphenbutazone and phenylbutazone.
142. Tanderil in surgery of rheumatic diseases. A double blind trial at dorsal synovectomy of the wrist joint.
143. Drug reactions. XX. Cutaneous reactions to anticonvulsants.
144. Aplastic anaemia. 3. Aplastic anaemia and infectious hepatitis.
145. [Bone marrow aplasia in the course of anti-epileptic treatments].
146. [Ketazon not more gentle to the stomach than Blutazolidin].
147. Hazards of drugs for rheumatoid arthritis.
148. [Tanderil, leukemia and statistics].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.